A Realistic View on "the Essential Medicinal Chemistry of Curcumin"

ACS Medicinal Chemistry Letters

Volumn 8, Issue 9, 2017, Pages 893-896

  Bahadori, Fatemeh ^a   Demiray, Mutlu ^b,c  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b Medicana International Istanbul   (Turkey)

^c KTO KARATAY UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

BIOLOGICAL ACTIVITY; DRUG SOLUBILITY; DRUG STABILITY; LETTER; MEDICINAL CHEMISTRY; PRIORITY JOURNAL;

EID: 85029494177     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.7b00284     Document Type: Letter

References (41)

1. Nelson, K. M.; Dahlin, J. L.; Bisson, J.; Graham, J.; Pauli, G. F.; Walters, M. A. The Essential Medicinal Chemistry of Curcumin J. Med. Chem. 2017, 60 (5) 1620-1637 10.1021/acs.jmedchem.6b00975
2. Wang, Y.-J.; Pan, M.-H.; Cheng, A.-L.; Lin, L.-I.; Ho, Y.-S.; Hsieh, C.-Y.; Lin, J.-K. Stability of curcumin in buffer solutions and characterization of its degradation products J. Pharm. Biomed. Anal. 1997, 15, 1867 10.1016/S0731-7085(96)02024-9
3. Yang, K.-Y.; Lin, L.-C.; Tseng, T.-Y.; Wang, S.-C.; Tsai, T.-H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 853, 183 10.1016/j.jchromb.2007.03.010
4. Decision tree. https://www.nc3rs.org.uk/rat-decision-tree-blood-sampling.
5. Burgos-Morón, E.; Calderón-Montaño, J. M.; Salvador, J.; Robles, A.; López-Lázaro, M. The dark side of curcumin Int. J. Cancer 2010, 126, 24967 10.1002/ijc.24967
6. Kurien, B. T.; Dillon, S. P.; Dorri, Y.; D'souza, A.; Scofield, R. H. Curcumin does not bind or intercalate into DNA and a note on the gray side of curcumin Int. J. Cancer 2011, 128, 242 10.1002/ijc.25290
7. Baell, J. B.; Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays J. Med. Chem. 2010, 53, 2719 10.1021/jm901137j
8. Baell, J. B. Feeling nature's PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS) J. Nat. Prod. 2016, 79, 616 10.1021/acs.jnatprod.5b00947
9. Kaposztas, Z.; Kahan, B. D.; Katz, S. M.; Van Buren, C. T.; Cherem, L. Bortezomib Successfully Reverses Early Recurrence of Light-Chain Deposition Disease in a Renal Allograft: A Case Report Transplant. Proc. 2009, 41, 4407 10.1016/j.transproceed.2009.10.005
10. Demiray, M.; Sahinbas, H.; Atahan, S.; Demiray, H.; Selcuk, D.; Yildirim, I.; Atayoglu, A. T. Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report Complementary Therapies in Medicine 2016, 27, 108 10.1016/j.ctim.2016.06.009
11. Elad, S.; Meidan, I.; Sellam, G.; Simaan, S.; Zeevi, I.; Waldman, E.; Weintraub, M.; Revel-Vilk, S. Topical Curcumin for the Prevention of Oral Mucositis in Pediatric Patients: Case Series Alternative Therapies in Health and Medicine 2013, 19, 21
12. Makela, R.; Makila, H.; Peltomaa, R. Dietary Therapy in Patients With Inflammatory Arthritis Alternative Therapies in Health and Medicine 2017, 23, 34
13. Priyadarsini, K. I. Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells J. Photochem. Photobiol., C 2009, 10, 81 10.1016/j.jphotochemrev.2009.05.001
14. Reddy, A. R.; Dinesh, P.; Prabhakar, A. S.; Umasankar, K.; Shireesha, B.; Raju, M. B. A Comprehensive Review on SAR of Curcumin Mini-Rev. Med. Chem. 2013, 13, 1769 10.2174/1389557511313120007
15. Sarkar, F. H.; Li, Y. W.; Wang, Z. W.; Padhye, S. Lesson Learned from Nature for the Development of Novel Anti-Cancer Agents: Implication of Isoflavone, Curcumin, and their Synthetic Analogs Curr. Pharm. Des. 2010, 16, 1801 10.2174/138161210791208956
16. Dong, S.-H.; Nikolić, D.; Simmler, C.; Qiu, F.; Van Breemen, R. B.; Soejarto, D. D.; Pauli, G. F.; Chen, S.-N. Diarylheptanoids from Dioscorea villosa (wild yam) J. Nat. Prod. 2012, 75, 2168 10.1021/np300603z
17. Hajirahimkhan, A.; Simmler, C.; Dong, H.; Lantvit, D. D.; Li, G.; Chen, S.-N.; Nikolić, D.; Pauli, G. F.; Van Breemen, R. B.; Dietz, B. M. Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A Chem. Res. Toxicol. 2015, 28, 2130 10.1021/acs.chemrestox.5b00310
18. Maheshwari, R. K.; Singh, A. K.; Gaddipati, J.; Srimal, R. C. Multiple biological activities of curcumin: a short review Life Sci. 2006, 78, 2081 10.1016/j.lfs.2005.12.007
19. Vadhan-Raj, S.; Weber, D. M.; Wang, M.; Giralt, S. A.; Thomas, S. K.; Alexanian, R.; Zhou, X.; Patel, P.; Bueso-Ramos, C. E.; Newman, R. A.; Aggarwal, B. B. Curcumin Downregulates NF-kB and Related Genes in Patients with Multiple Myeloma: Results of a Phase I/II Study Blood 2007, 110, 1177
20. Esmaily, H.; Sahebkar, A.; Iranshahi, M.; Ganjali, S.; Mohammadi, A.; Ferns, G.; Ghayour-Mobarhan, M. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial Chin. J. Integr. Med. 2015, 21, 332 10.1007/s11655-015-2160-z
21. Nahar, P. P.; Slitt, A. L.; Seeram, N. P. Anti-inflammatory effects of novel standardized solid lipid curcumin formulations J. Med. Food 2015, 18, 786 10.1089/jmf.2014.0053
22. Kanai, M.; Otsuka, Y.; Otsuka, K.; Sato, M.; Nishimura, T.; Mori, Y.; Kawaguchi, M.; Hatano, E.; Kodama, Y.; Matsumoto, S. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients Cancer Chemother. Pharmacol. 2013, 71, 1521 10.1007/s00280-013-2151-8
23. Morimoto, T.; Sunagawa, Y.; Katanasaka, Y.; Hirano, S.; Namiki, M.; Watanabe, Y.; Suzuki, H.; Doi, O.; Suzuki, K.; Yamauchi, M. Drinkable preparation of theracurmin exhibits high absorption efficiency-A single-dose, double-blind, 4-way crossover study Biol. Pharm. Bull. 2013, 36, 1708 10.1248/bpb.b13-00150
24. Sasaki, H.; Sunagawa, Y.; Takahashi, K.; Imaizumi, A.; Fukuda, H.; Hashimoto, T.; Wada, H.; Katanasaka, Y.; Kakeya, H.; Fujita, M. Innovative preparation of curcumin for improved oral bioavailability Biol. Pharm. Bull. 2011, 34, 660 10.1248/bpb.34.660
25. Appendino, G.; Belcaro, G.; Cornelli, U.; Luzzi, R.; Togni, S.; Dugall, M.; Cesarone, M.; Feragalli, B.; Ippolito, E.; Errichi, B. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study Panminerva Med 2011, 53, 43
26. Belcaro, G.; Cesarone, M. R.; Dugall, M.; Pellegrini, L.; Ledda, A.; Grossi, M. G.; Togni, S.; Appendino, G. Efficacy and safety of Meriva (R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients Altern Med Rev 2010, 15, 337
27. Antony, B.; Merina, B.; Iyer, V.; Judy, N.; Lennertz, K.; Joyal, S. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95? CG (BiocurcumaxTM), A Novel Bioenhanced Preparation of Curcumin Indian journal of pharmaceutical sciences 2008, 70, 445 10.4103/0250-474X.44591
28. Chandran, B.; Goel, A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis Phytother. Res. 2012, 26, 1719 10.1002/ptr.4639
29. Sahebkar, A. Are Curcuminoids Effective C-Reactive Protein-Lowering Agents in Clinical Practice? Evidence from a Meta-Analysis Phytother. Res. 2014, 28, 633 10.1002/ptr.5045
30. Ara, S. A.; Mudda, J. A.; Lingappa, A.; Rao, P. Research on curcumin: A meta-analysis of potentially malignant disorders Journal of cancer research and therapeutics 2016, 12, 175 10.4103/0973-1482.171370
31. Daily, J. W.; Yang, M.; Park, S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials J. Med. Food 2016, 19, 717 10.1089/jmf.2016.3705
32. Payton, F.; Sandusky, P.; Alworth, W. L. NMR study of the solution structure of curcumin J. Nat. Prod. 2007, 70, 143 10.1021/np060263s
33. Griesser, M.; Pistis, V.; Suzuki, T.; Tejera, N.; Pratt, D. A.; Schneider, C. Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin J. Biol. Chem. 2011, 286, 1114 10.1074/jbc.M110.178806
34. Cuomo, J.; Appendino, G.; Dern, A. S.; Schneider, E.; McKinnon, T. P.; Brown, M. J.; Togni, S.; Dixon, B. M. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation J. Nat. Prod. 2011, 74, 664 10.1021/np1007262
35. Wu, D.; Wu, P.; Zhao, L.; Huang, L.; Zhang, Z.; Zhao, S.; Huang, J. NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis Medicine 2015, 94, e1687 10.1097/MD.0000000000001687
36. Kunnumakkara, A. B.; Guha, S.; Krishnan, S.; Diagaradjane, P.; Gelovani, J.; Aggarwal, B. B. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products Cancer Res. 2007, 67, 3853 10.1158/0008-5472.CAN-06-4257
37. Kunnumakkara, A. B.; Diagaradjane, P.; Anand, P.; Kuzhuvelil, H. B.; Deorukhkar, A.; Gelovani, J.; Guha, S.; Krishnan, S.; Aggarwal, B. B. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model Int. J. Cancer 2009, 125, 2187 10.1002/ijc.24593
38. Singh, S.; Aggarwal, B. B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane) J. Biol. Chem. 1995, 270, 24995 10.1074/jbc.270.42.24995
39. Aggarwal, S.; Ichikawa, H.; Takada, Y.; Sandur, S. K.; Shishodia, S.; Aggarwal, B. B. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation Molecular pharmacology 2006, 69, 17400 10.1124/mol.105.017400
40. Li, S.; Liu, Z.; Zhu, F.; Fan, X.; Wu, X.; Zhao, H.; Jiang, L. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor Oncol. Res. 2014, 21, 137 10.3727/096504013X13832473330032
41. Sun, Z.-J.; Chen, G.; Zhang, W.; Hu, X.; Liu, Y.; Zhou, Q.; Zhu, L.-X.; Zhao, Y.-F. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma Molecular pharmacology 2011, 79, 106 10.1124/mol.110.066910